| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,849 | 21,168 | 19,978 | 17,765 | | Cost of Revenue | 3,866 | 3,959 | 4,156 | 4,263 | | | Gross Profit |
-
| 17,209 | 15,822 | 13,502 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,905 | 13,019 | 11,832 | 11,638 | | Non Recurring | (179) | 179 |
-
|
-
| | Others | 964 | 1,583 | 1,037 | 442 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,428 | 2,953 | 1,422 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,293 | 2,428 | 2,953 | 1,422 | | Interest Expense | 749 | 991 | 1,151 | 1,314 | | Income Before Tax | 544 | 1,437 | 1,802 | 108 | | Income Tax Expense | (92) | 21 | 140 | 21 | | Minority Interest | (1,307) |
-
|
-
| 404 | | | | Net Income From Continuing Ops | (671) | 1,416 | 1,662 | 491 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (671) | 1,416 | 1,662 | 491 | | Preferred Stock And Other Adjustments | 1,018 | (1,099) | (678) |
-
| | | Net Income Applicable To Common Shares | $347 | $317 | $984 | $491 |
|
0.51% Nasdaq 
Income Statement
